As a result, the Vk*MYC model provides a unique opportunity in future research to uncover the step-wise genomic events within plasma cells not otherwise feasible in human studies to be able define the genomic underpinnings of MM disease progression. This evidence concerns the gene MYC and Miyoshi myopathy.